Abstract: The present invention relates to an inverter device. Regard to the problem in the traditional convert device that the user is difficult to obtain the information shown on the display panel in time; the state of the inverter can not be switched remotely after the user leaves; discharging or early switching-off caused by missing battery information; and the draught fan can only be at the state of ‘full-speed-start’ or switch-off, the invention provides an inverter device, it is configured with an extensible flexible wire to fix the display panel of the inverter to the place the user wants to for getting the information of the inverter in time; by virtue of wireless transmission, user can control the state of the inverter remotely; by adding a test module to the inverter device, it avoids the waste of electricity which is caused by the discharging of the battery-to-convert and switching off.

Abstract: The present invention relates to a charging system based on wireless communication comprising: a mobile terminal, configured to transmit a control instruction and receive the query data matching user's selection according to the user's selection; a charging system, configured to receive the control instruction and charge a rechargeable battery pack according to the control instruction; a wireless communication, configured to interact with data between the mobile terminal and the charging system; wherein, the mobile terminal comprises: a query unit, configured to receive the query data inputted by the user and read the query data stored in a memory unit and matching the query according to the query data. User may get a charging curve and/or a remaining charging time according to the acquisition data. After charging completes, the mobile terminal will send a control instruction to stop charging so as to save energy and protect the battery.

Abstract: A charger system for battery starting current test, comprising: a battery equivalent circuit comprising a battery internal resistance R0 and an electromotive force E connected in series, two ends of the battery equivalent circuit are connected to a first signal and a second signal, respectively; a signal drive circuit, comprising a first DC output signal and a second DC output signal, and a first load circuit and a second load circuit configured between the first DC output signal and the second DC output signal, each load circuit is connected to the battery equivalent circuit and controlled by a first drive signal and a second drive signal; an intermediate resistor R28, configured between the signal drive circuit and the battery equivalent circuit. This invention uses the above technical solution to test the internal resistance of the battery, and find out the CCA value of the battery via the internal resistance correspondingly.

Abstract: Described herein are methods for treating inflammation in a subject comprising administering to the subject an effective amount of a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with a C1-C10 unsubstituted alkyl group or fluoroalkyl group.

Abstract: The present invention relates to an inverter device. Regard to the problem in the traditional convert device that the user is difficult to obtain the information shown on the display panel in time; the state of the inverter can not be switched remotely after the user leaves; discharging or early switching-off caused by missing battery information; and the draught fan can only be at the state of ‘full-speed-start’ or switch-off, the invention provides an inverter device, it is configured with an extensible flexible wire to fix the display panel of the inverter to the place the user wants to for getting the information of the inverter in time; by virtue of wireless transmission, user can control the state of the inverter remotely; by adding a test module to the inverter device, it avoids the waste of electricity which is caused by the discharging of the battery-to-convert and switching off.

Abstract: Described herein are methods for treating inflammation in a subject comprising administering to the subject an effective amount of a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with a C1-C10 unsubstituted alkyl group or fluoroalkyl group.

Abstract: Described herein are methods for treating a dental disorder in a subject comprising administering to the subject an effective amount of a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with a C1-C10 unsubstituted alkyl group or fluoroalkyl group.

Abstract: Described herein are methods for treating a dental disorder in a subject comprising administering to the subject an effective amount of a modified hyaluronan or a pharmaceutically acceptable salt or ester thereof, wherein said hyaluronan or its pharmaceutically acceptable salt or ester comprises at least one sulfate group and the primary C-6 hydroxyl proton of at least one N-acetyl-glucosamine residue is substituted with a C1-C10 unsubstituted alkyl group or fluoroalkyl group.

Abstract: Described herein are modified gelatins or the pharmaceutically-acceptable salts or esters thereof comprising at least one actinically crosslinkable group covalently bonded to gelatin. The modified gelatins are useful in producing composites that ultimately can be used to produce three-dimensional engineered biological constructs. The composites are the polymerization product between the modified gelatin and at least one actinically crosslinkable macromolecule. Methods for making the modified gelatins are also described herein.

Abstract: Described herein is the synthesis of alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including wound healing, drug delivery, and the treatment of a number of inflammatory diseases and skin disorders.

Abstract: Described herein are alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated and alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including use for ocular or ophthalmic treatment.

Abstract: Described herein are alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated and alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including use for ocular or ophthalmic treatment.

Abstract: Described herein are composites useful in tissue and organ engineering. In one aspect, the composite comprises the reaction product between a macromolecule comprising at least one thiol group and a gold nanoparticle. The thiolated macro-molecule crosslinks with the gold nanoparticle to produce a composite that is useful in anchoring cells. The composites can be used to form multi-layer 3-D structures, where the cells in each layer can aggregate and fuse with one another to form tissues and organs.

Abstract: The invention relates to a method for fractionally converting pennisetum hydridum into fuel ethanol with co-production of electricity generation and paper pulp, which comprises subjecting the pennisetum hydridum having been cut into segments to steam explosion treatment by utilizing a steam explosion device to obtain a steam explosion product, and said method is characterized in that it comprises the steps of: washing the steam explosion product with water to obtain fibers and water washing liquid containing a degraded hemicellulose, and separating and purifying the water washing liquid to obtain an xylo-oligosaccharide; fractionally teasing the fibers, and subjecting the obtained long fibers to an ethanol self-catalyzed pulping and then a bleaching treatment to obtain a paper pulp, and after recovering ethanol, obtaining an alcohol-soluble lignin by separation; preparing cellulase by a solid state fermentation, that is, taking the short fibers obtained by fractionally teasing as a fermentation substrate of T

Abstract: Described herein are composites produced by reacting a first thiolated macromolecule with at least one compound having at least one thiol-reactive electrophilic functional group. The methods described herein permit the cross-linking of a variety of different thiolated macromolecules with one another. The composites described herein have a variety of biomedical and pharmaceutical applications, which are also described herein.

Abstract: Described herein is the synthesis of alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including wound healing, drug delivery, and the treatment of a number of inflammatory diseases and skin disorders.

Abstract: Described herein is the synthesis of alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including wound healing, drug delivery, and the treatment of a number of inflammatory diseases and skin disorders.